scholarly journals Targeted therapy with anlotinib for a H3K27M mutation diffuse middle glioma patient with PDGFR-α mutation: a case report

2021 ◽  
Author(s):  
Qiang Wang ◽  
Wenhao Niu ◽  
Hao Pan
Keyword(s):  
Case Report ◽  
Targeted Therapy ◽  
Glioma Patient ◽  
H3k27m Mutation

scholarly journals Nanoparticle Albumin-Bound-Paclitaxel in the Treatment of Metastatic Urethral Adenocarcinoma: The Significance of Molecular Profiling and Targeted Therapy

2014 ◽  
Vol 2014 ◽  
pp. 1-3 ◽  
Author(s):  
Yasmin M. Abaza ◽  
Carlos Alemany
Keyword(s):  
Bladder Cancer ◽  
Case Report ◽  
Targeted Therapy ◽  
Therapeutic Approach ◽  
Metastatic Breast ◽  
Molecular Profiling ◽  
Genitourinary Tract ◽  
First Case

Primary urethral cancer is rare and accounts for only 0.003% of all malignancies arising from the female genitourinary tract. Due to the rarity of this disease, no consensus exists regarding the optimal therapeutic approach. Nanoparticle albumin-bound-paclitaxel has been shown to be effective in the treatment of a number of malignancies including metastatic breast, pancreatic, and bladder cancer. We present a 67-year-old woman with advanced metastatic urethral adenocarcinoma resistant to two lines of chemotherapy (ifosfamide/paclitaxel/cisplatin and irinotecan/5-fluorouracil/leucovorin) that showed a dramatic response to nanoparticle albumin-bound-paclitaxel. This is the first case report to document the use and efficacy of nanoparticle albumin-bound-paclitaxel in the treatment of unresectable metastatic urethral cancer.

scholarly journals Rare occurrence of cavitation of lung metastases following effective targeted therapy: A case report

2016 ◽  
Vol 11 (2) ◽  
pp. 1589-1591
Author(s):  
JIACHENG SONG ◽  
JING YU ◽  
ZHANLONG MA ◽  
SHANSHAN LU
Keyword(s):  
Case Report ◽  
Targeted Therapy ◽  
Lung Metastases ◽  
Rare Occurrence

Targeted Therapy in Collecting Duct Carcinoma of the Kidney: A Case Report and Literature Review

2016 ◽  
Vol 14 (2) ◽  
pp. e203-e206 ◽  
Author(s):  
Ming Yin ◽  
Wenge Wang ◽  
Jennifer Rosenberg ◽  
Matthew Kaag ◽  
Monika Joshi ◽  
...  
Keyword(s):  
Case Report ◽  
Targeted Therapy ◽  
Literature Review ◽  
Collecting Duct ◽  
Duct Carcinoma ◽  
Collecting Duct Carcinoma

scholarly journals HER2-Positive Neuroendocrine Breast Cancer: Case Report and Review of Literature

Breast Care ◽  
2016 ◽  
Vol 11 (6) ◽  
pp. 424-426 ◽  
Author(s):  
Arpine Gevorgyan ◽  
Giacomo Bregni ◽  
Giulia Galli ◽  
Elisa Zanardi ◽  
Filippo de Braud ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Case Report ◽  
Targeted Therapy ◽  
Neuroendocrine Carcinoma ◽  
Immunohistochemical Analysis ◽  
Breast Cancer Case ◽  
Cancer Case ◽  
Review Of Literature ◽  
Her2 Amplification ◽  
Her2 Positive

Background: Neuroendocrine carcinoma is an uncommon histology for breast cancer. Case Report: Our patient underwent right quadrantectomy for a neuroendocrine carcinoma in 1984 and had a bone relapse 30 years later. After thorough pathological and immunohistochemical analysis the diagnosis was confirmed and HER2 amplification was observed. Here we discuss the management, rationale and results of HER2-targeted therapy in advanced neuroendocrine breast carcinoma.

scholarly journals Case report of a young patient with a massively disseminated malignant melanoma treated with targeted therapy

Onkologie ◽  
2020 ◽  
Vol 14 (Suppl.E) ◽  
pp. 119-121
Author(s):  
Jiří Navrátil ◽  
Radek Lakomý ◽  
Alexandr Poprach ◽  
Jiří Vašina
Keyword(s):  
Case Report ◽  
Targeted Therapy ◽  
Malignant Melanoma ◽  
Young Patient
Sign in / Sign up

Export Citation Format

Share Document